Surgically treated diaphragmatic perforation after radiofrequency ablation for hepatocellular carcinoma

por Nagasu, Sachiko, Okuda, Koji, Kuromatsu, Ryoko, Nomura, Yoriko, Torimura, Takuji, Akagi, Yoshito
Publicado 2017

Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases

por KAWAGUCHI, TAKUMI, NAKANO, MASAHITO, SATANI, MANABU, SUMIE, SHUJI, YAMADA, SHINGO, AMANO, KEISUKE, KUROMATSU, RYOKO, SATA, MICHIO
Publicado 2014

Short-term efficacy after switching from adefovir dipivoxil and tenofovir disoproxil fumarate therapy to tenofovir alaferamide for chronic hepatitis B

por Sano, Tomoya, Amano, Keisuke, Ide, Tatsuya, Kawaguchi, Toshihiro, Kuwahara, Reiichiro, Arinaga-Hino, Teruko, Koga, Hironori, Kuromatsu, Ryoko, Torimura, Takuji
Publicado 2021

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection

por Sumie, Shuji, Kawaguchi, Takumi, Kuromatsu, Ryoko, Takata, Akio, Nakano, Masahito, Satani, Manabu, Yamada, Shingo, Niizeki, Takashi, Torimura, Takuji, Sata, Michio
Publicado 2011

Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis

por Nakano, Masahito, Kuromatsu, Ryoko, Niizeki, Takashi, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Koga, Hironori, Torimura, Takuji
Publicado 2020

Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma

por Okamura, Shusuke, Shimose, Shigeo, Niizeki, Takashi, Kamachi, Naoki, Noda, Yu, Shirono, Tomotake, Iwamoto, Hideki, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2022

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound

por Kamachi, Naoki, Nakano, Masahito, Okamura, Shusuke, Niizeki, Takashi, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2021

Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review

por Suzuki, Hiroyuki, Iwamoto, Hideki, Shimose, Shigeo, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Yamaguchi, Taizo, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Kawaguchi, Takumi
Publicado 2022

Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching

por Shimose, Shigeo, Iwamoto, Hideki, Niizeki, Takashi, Tanaka, Masatoshi, Shirono, Tomotake, Moriyama, Etsuko, Noda, Yu, Nakano, Masahito, Suga, Hideya, Kuromatsu, Ryoko, Torimura, Takuji, Koga, Hironori, Kawaguchi, Takumi
Publicado 2023

Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study

por Nakano, Masahito, Tanaka, Masatoshi, Kuromatsu, Ryoko, Nagamatsu, Hiroaki, Satani, Manabu, Niizeki, Takashi, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Koga, Hironori, Torimura, Takuji
Publicado 2016

Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion

por Niizeki, Takashi, Iwamoto, Hideki, Shirono, Tomotake, Shimose, Shigeo, Nakano, Masahito, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Hiroyuki, Suzuki, Sakai, Miwa, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2021

Usefulness of a novel transarterial chemoinfusion plus external‐beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right...

por Shirono, Tomotake, Koga, Hironori, Niizeki, Takashi, Nagamatsu, Hiroaki, Iwamoto, Hideki, Shimose, Shigeo, Nakano, Masahito, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Kuromatsu, Ryoko, Ogo, Etsuyo, Torimura, Takuji
Publicado 2021

Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study

por Nakano, Masahito, Tanaka, Masatoshi, Kuromatsu, Ryoko, Nagamatsu, Hiroaki, Tajiri, Nobuyoshi, Satani, Manabu, Niizeki, Takashi, Aino, Hajime, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Koga, Hironori, Torimura, Takuji
Publicado 2015

Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

por Shirono, Tomotake, Iwamoto, Hideki, Niizeki, Takashi, Shimose, Shigeo, Kajiwara, Akira, Suzuki, Hiroyuki, Kamachi, Naoki, Noda, Yu, Okamura, Shusuke, Nakano, Masahito, Kuromatsu, Ryoko, Murotani, Kenta, Koga, Hironori, Torimura, Takuji
Publicado 2022

Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study

por Shimose, Shigeo, Iwamoto, Hideki, Tanaka, Masatoshi, Niizeki, Takashi, Kajiwara, Masahiko, Itano, Satoshi, Moriyama, Etsuko, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Kawaguchi, Takumi
Publicado 2022

The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

por Shimose, Shigeo, Iwamoto, Hideki, Shirono, Tomotake, Tanaka, Masatoshi, Niizeki, Takashi, Kajiwara, Masahiko, Itano, Satoshi, Yano, Yoichi, Matsugaki, Satoru, Moriyama, Etsuko, Noda, Yu, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Kawaguchi, Takumi
Publicado 2023

Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study

por Shimose, Shigeo, Iwamoto, Hideki, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Okamura, Shusuke, Nakano, Masahito, Suga, Hideya, Kuromatsu, Ryoko, Yamaguchi, Taizo, Kawaguchi, Takumi, Tanaka, Masatoshi, Noguchi, Kazunori, Koga, Hironori, Torimura, Takuji
Publicado 2020

Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study

por Shimose, Shigeo, Iwamoto, Hideki, Tanaka, Masatoshi, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Okamura, Shusuke, Nakano, Masahito, Suga, Hideya, Yamaguchi, Taizo, Kawaguchi, Takumi, Kuromatsu, Ryoko, Noguchi, Kazunori, Koga, Hironori, Torimura, Takuji
Publicado 2021

Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice

por Iwamoto, Hideki, Shimose, Shigeo, Noda, Yu, Shirono, Tomotake, Niizeki, Takashi, Nakano, Masahito, Okamura, Shusuke, Kamachi, Naoki, Suzuki, Hiroyuki, Sakai, Miwa, Kajiwara, Akira, Itano, Satoshi, Tanaka, Masatoshi, Yamaguchi, Taizo, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2021

Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer

por Kuromatsu, Ryoko, Ide, Tatsuya, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Nakano, Masahito, Shirono, Tomotake, Shimose, Shigeo, Iwamoto, Hideki, Kuwahara, Reiichiro, Arinaga-Hino, Teruko, Niizeki, Takashi, Zaizen, Yuki, Takaki, Hiroshi, Shirachi, Miki, Koga, Hironori, Torimura, Takuji
Publicado 2022